NCT/Study#
4895436 /
M20-356
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Venetoclax-Obinutuzumab Retreatment in Patients with Recurring Chronic Lymphocytic Leukemia
DISEASE GROUP:
Chronic Lymphocytic Leukemia
current phase:
Phase II
STUDY STATUS:
Enrolling
Location:
Little Silver, NJ
For More information:
Call (201) 518-3587
